This inventor holds 18 USPTO granted patents and 9 published patent applications and 6 EPO patents. Top assignees: Ono Pharmaceutical Co., Ltd., Hoffmann-La Roche Inc.. Active years: 2013-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
18 out of 575 
1 out of 5,026 
Years Active: 2013-2025
Title: Contributions of Toshio Yoshizawa in Cancer Therapy and Drug Innovation
Introduction: Toshio Yoshizawa, an accomplished inventor based in Osaka, Japan, has made significant contributions to the field of oncology through his innovative patent applications. With a total of 18 patents to his name, his work focuses on advancing therapies for cancer treatment.
Latest Patents: Two of Yoshizawa's latest patents exemplify his cutting-edge contributions. The first is titled "Combination therapy of an anti-CD20 antibody with a BTK inhibitor." This invention focuses on the synergy of a type I anti-CD20 antibody or an afucosylated humanized B-Ly1 antibody combined with a BTK inhibitor, specifically targeting CD20 expressing cancers. His second notable invention, "Purinone derivative hydrochloride," describes a purinone derivative with Btk-selective inhibitory activity. This compound is distinguished by its metabolic stability, high solubility, and absorption efficiency, making it an effective therapeutic agent for diseases associated with B cells and mast cells.
Career Highlights: Throughout his career, Yoshizawa has been affiliated with prominent pharmaceutical companies such as Ono Pharmaceutical Co., Ltd. and Hoffmann-La Roche Inc. His work has significantly enhanced the understanding and treatment options for various cancers, thereby impacting the pharmaceutical industry's approach to cancer therapies.
Collaborations: In his professional journey, Yoshizawa has collaborated with notable peers, including Shingo Yamamoto and Ryohei Kozaki. These collaborations have fostered a productive environment for innovation and have led to several advancements in drug development.
Conclusion: Toshio Yoshizawa's contributions to the field of cancer treatment through his patents underscore his role as a leading innovator in pharmaceutical sciences. His work not only paves the way for new therapeutic strategies but also highlights the importance of collaboration in achieving groundbreaking advancements in medicine. As he continues to explore new frontiers, the results of his inventions hold promise for improving patient outcomes in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile